{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["d182e680-646c-4cd3-a3d9-e66ea27d66b4", "Q3", 401105649, "MICHAEL YAKI CONSULTING", 205825, "ANTIMICROBIALS WORKING GROUPS", 2021, "third_quarter", "2021-10-04T16:46:29.620000-04:00", 30000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/d182e680-646c-4cd3-a3d9-e66ea27d66b4/\", \"filing_uuid\": \"d182e680-646c-4cd3-a3d9-e66ea27d66b4\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2021, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/d182e680-646c-4cd3-a3d9-e66ea27d66b4/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"30000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Michael J Yaki\", \"dt_posted\": \"2021-10-04T16:46:29.620000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"Po Box 387, The Sea Ranch, CA 95497\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"The Sea Ranch\", \"registrant_state\": \"CA\", \"registrant_zip\": \"95497\", \"registrant\": {\"id\": 401105649, \"url\": \"https://lda.senate.gov/api/v1/registrants/401105649/\", \"house_registrant_id\": null, \"name\": \"MICHAEL YAKI CONSULTING\", \"description\": \"Consulting\", \"address_1\": \"Po Box 387, The Sea Ranch, CA 95497\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"The Sea Ranch\", \"state\": \"CA\", \"state_display\": \"California\", \"zip\": \"95497\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"MICHAEL YAKI\", \"contact_telephone\": \"+1 415-601-4008\", \"dt_updated\": \"2023-09-11T13:25:20.039032-04:00\"}, \"client\": {\"id\": 205825, \"url\": \"https://lda.senate.gov/api/v1/clients/205825/\", \"client_id\": 12, \"name\": \"ANTIMICROBIALS WORKING GROUPS\", \"general_description\": \"Antimicrobial research and development\", \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"DC\", \"ppb_state_display\": \"District of Columbia\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2020-05-06\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Discuss w House and Senate staff on funding for antimicrobial commercialization\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 87825, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": \"JOHN\", \"last_name\": \"YAKI\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Discuss w House and Senate staff on funding for antimicrobial commercialization\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 87825, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": \"JOHN\", \"last_name\": \"YAKI\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"Discussion w House and Senate staff on funding for Antimicrobial commercialization\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 87825, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": \"JOHN\", \"last_name\": \"YAKI\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["d182e680-646c-4cd3-a3d9-e66ea27d66b4"], "units": {}, "query_ms": 1.908334088511765, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}